Cognitive bias modification treatment aims to help reduce symptoms of anxiety and depression by modifying implicit cognitive biases and changing negative thoughts patterns. Cognitive bias modification programs involve computerized training sessions designed to help individuals notice and redirect automatic negative thoughts that may be contributing to mental health issues like anxiety and depression. The global Cognitive Bias Modification Treatment Market is estimated to be valued at US$ 100 million in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of mental health issues such as anxiety and depression globally is expected to drive the cognitive bias modification treatment market during the forecast period. Anxiety and depression affects over 300 million people worldwide and their numbers continue to rise rapidly. Early childhood adversity, lack of social support and loneliness associated with modern life are exacerbating mental health concerns. Cognitive bias modification programs provides a digital solution to help identify and modify negative thought patterns associated with anxiety disorders and depression which may be stemming from cognitive biases formed due to adverse life experiences and stress. Growing awareness about benefits of cognitive bias modification treatment for mild to moderate mental health issues is boosting adoption.
Segment Analysis
The global cognitive bias modification treatment market can be segmented by type, technology, application, and geography. Based on type, the cognitive bias modification treatment market can be segmented into attention bias modification, interpretation bias modification, and approach bias modification. The attention bias modification segment holds the largest market share due to the increasing application to treat anxiety disorders.
Key Takeaways
The global cognitive bias modification treatment market is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: North America is currently the largest shareholder in the global cognitive bias modification treatment market. The presence of major market players and increasing funding for research and development are some factors attributed to dominance. Asia Pacific is expected to grow at the fastest rate over the forecast period due to a rising geriatric population and growing awareness about available treatment options.
Key players operating in the cognitive bias modification treatment market are pear Therapeutics, Anxiety and Depression Association of America, Advanced Bias Modification, Cognoa, Software BV, PBC, Mindstrong Health, Happy Faces, Jungle Labs.
No comments:
Post a Comment